Effects of δ opioid receptor stimulation via SNC80 on conditioned reinforcing properties of a remifentanil-associated stimulus

SNC80介导的δ阿片受体刺激对瑞芬太尼相关刺激的条件强化特性的影响

阅读:1

Abstract

Substance use disorder is associated with a high rate of relapse driven by the rewarding and motivational properties of drug-associated stimuli. We examined the extent to which the δ opioid receptor (DOR) mediated the conditioned reinforcing properties of drug-associated stimuli across 4 experiments and 2 operant procedures in Sprague-Dawley rats. In experiment 1, we assessed the extent to which SNC80 (DOR agonist) altered responding during extinction in a remifentanil self-administration procedure. In experiment 2, we assessed the extent to which SNC80 altered responding for a remifentanil-associated stimulus in the new response acquisition procedure. In experiment 3, we assessed the extent to which the effects of SNC80 were altered in standard versus enhanced stimulus control conditions in the new response acquisition procedure. In experiment 4, we assessed the extent to which naltrindole (DOR antagonist) was able to block SNC80-induced alterations in responding for a remifentanil-associated stimulus in the new response acquisition procedure. In experiment 5, we assessed the extent to which pretreatments of SNC80 altered Pavlovian conditioning in the new response acquisition procedure. These experiments support the role of the DOR system in mediating the rewarding properties of drug-associated stimuli, such that SNC80 dose-dependently enhanced responding for a remifentanil-associated stimulus across self-administration and new response acquisition procedures. These effects were blocked by naltrindole, demonstrating that these are DOR-mediated effects. DORs may represent a promising target to address relapse. SIGNIFICANCE STATEMENT: Conditioned reinforcing effects of an opioid-associated cue were enhanced following stimulation of δ opioid receptors (DORs), and this effect was blocked via DOR antagonism, which suggests the role of DORs in mediating drug-associated conditioned reinforcement.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。